Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.

Male Humans Female Osteoporotic Fractures / etiology Osteoporosis / complications Hip Fractures / etiology Bone Density Risk Factors Risk Assessment
Hip fracture Major osteoporotic fracture Meta-analysis Osteoporotic fracture Prior fracture

Journal

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
ISSN: 1433-2965
Titre abrégé: Osteoporos Int
Pays: England
ID NLM: 9100105

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 22 03 2023
accepted: 22 07 2023
medline: 16 11 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

A large international meta-analysis using primary data from 64 cohorts has quantified the increased risk of fracture associated with a previous history of fracture for future use in FRAX. The aim of this study was to quantify the fracture risk associated with a prior fracture on an international basis and to explore the relationship of this risk with age, sex, time since baseline and bone mineral density (BMD). We studied 665,971 men and 1,438,535 women from 64 cohorts in 32 countries followed for a total of 19.5 million person-years. The effect of a prior history of fracture on the risk of any clinical fracture, any osteoporotic fracture, major osteoporotic fracture, and hip fracture alone was examined using an extended Poisson model in each cohort. Covariates examined were age, sex, BMD, and duration of follow-up. The results of the different studies were merged by using the weighted β-coefficients. A previous fracture history, compared with individuals without a prior fracture, was associated with a significantly increased risk of any clinical fracture (hazard ratio, HR = 1.88; 95% CI = 1.72-2.07). The risk ratio was similar for the outcome of osteoporotic fracture (HR = 1.87; 95% CI = 1.69-2.07), major osteoporotic fracture (HR = 1.83; 95% CI = 1.63-2.06), or for hip fracture (HR = 1.82; 95% CI = 1.62-2.06). There was no significant difference in risk ratio between men and women. Subsequent fracture risk was marginally downward adjusted when account was taken of BMD. Low BMD explained a minority of the risk for any clinical fracture (14%), osteoporotic fracture (17%), and for hip fracture (33%). The risk ratio for all fracture outcomes related to prior fracture decreased significantly with adjustment for age and time since baseline examination. A previous history of fracture confers an increased risk of fracture of substantial importance beyond that explained by BMD. The effect is similar in men and women. Its quantitation on an international basis permits the more accurate use of this risk factor in case finding strategies.

Identifiants

DOI: 10.1007/s00198-023-06870-z PMID: 37566158 PMC: PMC7615305
pubmed: 37566158
doi: 10.1007/s00198-023-06870-z
pii: 10.1007/s00198-023-06870-z
pmc: PMC7615305
mid: EMS187236
doi:

Types de publication

Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2027-2045

Subventions

Organisme : NHLBI NIH HHS
ID : 75N92021D00002
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : WHI NIH HHS
ID : 75N92021D00005
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92021D00001
Pays : United States
Organisme : WHI NIH HHS
ID : 75N92021D00003
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_21036
Pays : United Kingdom
Organisme : WHI NIH HHS
ID : 75N92021D00004
Pays : United States

Informations de copyright

© 2023. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.

Références

Osteoporos Int. 2021 Aug;32(8):1547-1555
pubmed: 33537845
Osteoporos Int. 2014 Oct;25(10):2359-81
pubmed: 25182228
Osteoporos Int. 2017 Mar;28(3):775-780
pubmed: 28028554
Osteoporos Int. 2022 Oct;33(10):2049-2102
pubmed: 35478046
J Bone Miner Res. 2005 Jul;20(7):1185-94
pubmed: 15940371
EClinicalMedicine. 2021 May 05;35:100826
pubmed: 34124629
Osteoporos Int. 2008 Oct;19(10):1431-44
pubmed: 18324342
CMAJ. 2010 Nov 23;182(17):1864-73
pubmed: 20940232
Bone. 2003 Oct;33(4):522-32
pubmed: 14555255
J Bone Miner Res. 1999 May;14(5):821-8
pubmed: 10320531
Osteoporos Int. 2021 Oct;32(10):1951-1960
pubmed: 33813622
Lancet Diabetes Endocrinol. 2019 Jan;7(1):34-43
pubmed: 30503163
Osteoporos Int. 2022 Oct;33(10):2103-2136
pubmed: 35639106
J Bone Miner Res. 2000 Apr;15(4):721-39
pubmed: 10780864
IARC Sci Publ. 1987;(82):1-406
pubmed: 2577937
J Bone Miner Res. 2000 Jan;15(1):20-3
pubmed: 10646110
Arch Osteoporos. 2022 Apr 5;17(1):58
pubmed: 35378630
Arch Osteoporos. 2012;7:3-20
pubmed: 23203733
Calcif Tissue Int. 2012 Jan;90(1):1-13
pubmed: 22057815
J Clin Endocrinol Metab. 2005 Mar;90(3):1583-7
pubmed: 15613428
J Bone Miner Res. 2010 Jun;25(6):1400-5
pubmed: 20200950
J Clin Endocrinol Metab. 2023 Feb 15;108(3):745-754
pubmed: 36201517
Osteoporos Int. 2001;12(5):417-27
pubmed: 11444092
Osteoporos Int. 2019 Jan;30(1):3-44
pubmed: 30324412
Osteoporos Int. 2001;12(3):207-14
pubmed: 11315239
Bone. 2004 Aug;35(2):375-82
pubmed: 15268886
J Clin Endocrinol Metab. 2016 May;101(5):2149-59
pubmed: 26918292
Bone. 2003 Oct;33(4):505-13
pubmed: 14555253
BMJ. 2009 Nov 19;339:b4229
pubmed: 19926696
Osteoporos Int. 2022 Dec;33(12):2507-2515
pubmed: 36161339
J Bone Miner Res. 2014 Mar;29(3):518-30
pubmed: 24443324
Osteoporos Int. 2018 Aug;29(8):1747-1757
pubmed: 29947869
Bone. 2019 Mar;120:85-93
pubmed: 30315999
Bone. 2015 Sep;78:216-24
pubmed: 25988660
Osteoporos Int. 2006;17(9):1353-7
pubmed: 16823545
Osteoporos Int. 2022 Aug;33(8):1725-1738
pubmed: 35451623
Osteoporos Int. 2007 Jun;18(6):761-70
pubmed: 17245546
Osteoporos Int. 2020 Jun;31(6):1059-1067
pubmed: 32173782
J Am Geriatr Soc. 1994 May;42(5):481-9
pubmed: 8176141
Osteoporos Int. 2006;17(3):319-36
pubmed: 16341622
Osteoporos Int. 2004 Mar;15(3):175-9
pubmed: 14691617
J Bone Miner Res. 2004 Dec;19(12):1933-44
pubmed: 15537435
Osteoporos Int. 2015 Feb;26(2):513-9
pubmed: 25187120
Arch Osteoporos. 2016 Dec;11(1):25
pubmed: 27465509
Osteoporos Int. 2022 Mar;33(3):541-548
pubmed: 34839377

Auteurs

J A Kanis (JA)

Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia. w.j.Pontefract@sheffield.ac.uk.
Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK. w.j.Pontefract@sheffield.ac.uk.
ORCID: 0000-0002-3129-4326

H Johansson (H)

Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
Sahlgrenska Osteoporosis Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.

E V McCloskey (EV)

Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.
MRC Versus Arthritis Centre for Integrated research in Musculoskeletal Ageing, Mellanby Centre for Musculoskeletal Research, University of Sheffield, Sheffield, UK.

E Liu (E)

Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.

K E Åkesson (KE)

Clinical and Molecular Osteoporosis Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.
Department of Orthopedics, Skåne University Hospital, Malmö, Sweden.

F A Anderson (FA)

GLOW Coordinating Center, Center for Outcomes Research, University of Massachusetts Medical School, Worcester, MA, USA.

R Azagra (R)

Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
Health Centre Badia del Valles, Catalan Institute of Health, Barcelona, Spain.
PRECIOSA-Fundación para la investigación, Barberà del Vallés, Barcelona, Spain.

C L Bager (CL)

Nordic Bioscience A/S, Herlev, Denmark.

C Beaudart (C)

WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Division of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.
Department of Health Services Research, University of Maastricht, Maastricht, the Netherlands.

H A Bischoff-Ferrari (HA)

Department of Aging Medicine and Aging Research, University Hospital, Zurich, and University of Zurich, Zurich, Switzerland.
Centre on Aging and Mobility, University of Zurich and City Hospital, Zurich, Switzerland.

E Biver (E)

Division of Bone Diseases, Department of Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.

O Bruyère (O)

WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Division of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium.

J A Cauley (JA)

Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Philadelphia, USA.

J R Center (JR)

Skeletal Diseases Program, Garvan Institute of Medical Research, Sydney, NSW, Australia.
St Vincent's Clinical School, School of Medicine and Health, University of New South Wales Sydney, Sydney, NSW, Australia.
School of Medicine Sydney, University of Notre Dame Australia, Sydney, NSW, Australia.

R Chapurlat (R)

INSERM UMR 1033, Université Claude Bernard-Lyon1, Hôpital Edouard Herriot, Lyon, France.

C Christiansen (C)

Nordic Bioscience A/S, Herlev, Denmark.

C Cooper (C)

MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospitals Southampton NHS Foundation Trust, Southampton, UK.
NIHR Oxford Biomedical Research Unit, University of Oxford, Oxford, UK.

C J Crandall (CJ)

Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

S R Cummings (SR)

San Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, CA, USA.

J A P da Silva (JAP)

Coimbra Institute for Clinical and Biomedical Research, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.

B Dawson-Hughes (B)

Bone Metabolism Laboratory, Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA.

A Diez-Perez (A)

Department of Internal Medicine, Hospital del Mar and CIBERFES, Autonomous University of Barcelona, Barcelona, Spain.

A B Dufour (AB)

Marcus Institute for Aging Research, Hebrew Senior Life, Boston, MA, USA.
Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

J A Eisman (JA)

Skeletal Diseases Program, Garvan Institute of Medical Research, Sydney, NSW, Australia.
St Vincent's Clinical School, School of Medicine and Health, University of New South Wales Sydney, Sydney, NSW, Australia.
School of Medicine Sydney, University of Notre Dame Australia, Sydney, NSW, Australia.

P J M Elders (PJM)

Petra JM Elders Department of General Practice, Amsterdam UMC, location AMC, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.

S Ferrari (S)

Division of Bone Diseases, Department of Medicine, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Y Fujita (Y)

Center for Medical Education and Clinical Training, Kindai University Faculty of Medicine, Osaka, Japan.

S Fujiwara (S)

Department of Pharmacy, Yasuda Women's University, Hiroshima, Japan.

C-C Glüer (CC)

Section Biomedical Imaging, Molecular Imaging North Competence Center, Department of Radiology and Neuroradiology, University Medical Center Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.

I Goldshtein (I)

Maccabitech Institute of Research and Innovation, Maccabi Healthcare Services, Tel Aviv, Israel.
Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

D Goltzman (D)

Department of Medicine, McGill University and McGill University Health Centre, Montreal, Canada.

V Gudnason (V)

Icelandic Heart Association, Kopavogur, Iceland.
University of Iceland, Reykjavik, Iceland.

J Hall (J)

MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK.

D Hans (D)

Interdisciplinary Centre of Bone Diseases, Bone and Joint Department, Lausanne University Hospital (CHUV) & University of Lausanne, Lausanne, Switzerland.

M Hoff (M)

Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Rheumatology, St Olavs Hospital, Trondheim, Norway.

R J Hollick (RJ)

Aberdeen Centre for Arthritis and Musculoskeletal Health, Epidemiology Group, University of Aberdeen, Aberdeen, UK.

M Huisman (M)

Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
Department of Sociology, VU University, Amsterdam, The Netherlands.

M Iki (M)

Department of Public Health, Kindai University Faculty of Medicine, Osaka, Japan.

S Ish-Shalom (S)

Endocrine Clinic, Elisha Hospital, Haifa, Israel.

G Jones (G)

Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.

M K Karlsson (MK)

Clinical and Molecular Osteoporosis Research Unit, Department of Clinical Sciences, Lund University, Lund, Sweden.
Department of Orthopedics, Skåne University Hospital, Malmö, Sweden.

S Khosla (S)

Robert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA.

D P Kiel (DP)

Marcus Institute for Aging Research, Hebrew Senior Life, Boston, MA, USA.
Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

W-P Koh (WP)

Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore, Singapore.

F Koromani (F)

Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.

M A Kotowicz (MA)

IMPACT (Institute for Mental and Physical Health and Clinical Translation), Deakin University, Geelong, Victoria, Australia.
Barwon Health, Geelong, Victoria, Australia.
Department of Medicine -Western Health, The University of Melbourne, St Albans, Victoria, Australia.

H Kröger (H)

Department of Orthopedics and Traumatology, Kuopio University Hospital, Kuopio, Finland.
Kuopio Musculoskeletal Research Unit, University of Eastern Finland, Kuopio, Finland.

T Kwok (T)

Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
Jockey Club Centre for Osteoporosis Care and Control, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong.

O Lamy (O)

Centre of Bone Diseases, Lausanne University Hospital, Lausanne, Switzerland.
Service of Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland.

A Langhammer (A)

HUNT Research Centre, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.

B Larijani (B)

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

K Lippuner (K)

Department of Osteoporosis, Bern University Hospital, University of Bern, Bern, Switzerland.

D Mellström (D)

Geriatric Medicine, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Geriatric Medicine, Sahlgrenska University Hospital Mölndal, Mölndal, Sweden.

T Merlijn (T)

Department of General Practice, Amsterdam UMC, location AMC, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.

A Nordström (A)

School of Sport Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
Department of Health Sciences, Swedish Winter Sports Research Centre, Mid Sweden University, Östersund, Sweden.
Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

P Nordström (P)

Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.

T W O'Neill (TW)

National Institute for Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Centre for Epidemiology Versus Arthritis, University of Manchester, Manchester, UK.

B Obermayer-Pietsch (B)

Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University Graz, Graz, Austria.
Center for Biomarker Research in Medicine, Graz, Austria.

C Ohlsson (C)

Sahlgrenska Osteoporosis Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Drug Treatment, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.

E S Orwoll (ES)

Department of Medicine, Oregon Health and Science University, Portland, OR, USA.

J A Pasco (JA)

IMPACT (Institute for Mental and Physical Health and Clinical Translation), Deakin University, Geelong, Victoria, Australia.
Barwon Health, Geelong, Victoria, Australia.
Department of Medicine -Western Health, The University of Melbourne, St Albans, Victoria, Australia.
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.

F Rivadeneira (F)

Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.

A-M Schott (AM)

Université Claude Bernard Lyon 1, U INSERM 1290 RESHAPE, Lyon, France.

E J Shiroma (EJ)

Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Baltimore, MD, USA.

K Siggeirsdottir (K)

Icelandic Heart Association, Kopavogur, Iceland.
Janus Rehabilitation, Reykjavik, Iceland.

E M Simonsick (EM)

Translational Gerontology Branch, National Institute on Aging Intramural Research Program, Baltimore, MD, USA.

E Sornay-Rendu (E)

INSERM UMR 1033, University of Lyon, Hôpital Edouard Herriot, Lyon, France.

R Sund (R)

Kuopio Musculoskeletal Research Unit, University of Eastern Finland, Kuopio, Finland.

K M A Swart (KMA)

Petra JM Elders Department of General Practice, Amsterdam UMC, location AMC, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.

P Szulc (P)

INSERM UMR 1033, University of Lyon, Hôpital Edouard Herriot, Lyon, France.

J Tamaki (J)

Department of Hygiene and Public Health, Faculty of Medicine, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka, Japan.

D J Torgerson (DJ)

York Trials Unit, Department of Health Sciences, University of York, York, UK.

N M van Schoor (NM)

Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.

T P van Staa (TP)

Centre for Health Informatics, Faculty of Biology, Medicine and Health, School of Health Sciences, University of Manchester, Manchester, UK.

J Vila (J)

Statistics Support Unit, Hospital del Mar Medical Research Institute, CIBER Epidemiology and Public Health (CIBERESP), Barcelona, Spain.

N J Wareham (NJ)

MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.

N C Wright (NC)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

N Yoshimura (N)

Department of Preventive Medicine for Locomotive Organ Disorders, The University of Tokyo Hospital, Tokyo, Japan.

M C Zillikens (MC)

Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.

M Zwart (M)

PRECIOSA-Fundación para la investigación, Barberà del Vallés, Barcelona, Spain.
Health Center Can Gibert del Plà, Catalan Institute of Health, Girona, Spain.
Department of Medical Sciences, University of Girona, Girona, Spain.
GROIMAP/GROICAP (research groups), Unitat de Suport a la Recerca Girona, Institut Universitari d'Investigació en Atenció Primària Jordi Gol, Girona, Spain.

L Vandenput (L)

Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
Sahlgrenska Osteoporosis Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

N C Harvey (NC)

MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospitals Southampton NHS Foundation Trust, Southampton, UK.

M Lorentzon (M)

Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia.
Sahlgrenska Osteoporosis Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.

W D Leslie (WD)

Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Previous fracture and subsequent fracture...
questionsmedicales.fr › Plaies et blessures › Fractures osseuses › Fractures ostéoporotiques › Previous fracture and subsequent fracture...
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Maladies osseuses métaboliques › Ostéoporose › Previous fracture and subsequent fracture...
questionsmedicales.fr › Plaies et blessures › Traumatismes de la jambe › Fractures du fémur › Fractures de la hanche › Previous fracture and subsequent fracture...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système locomoteur › Densité osseuse › Previous fracture and subsequent fracture...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Previous fracture and subsequent fracture...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › Previous fracture and subsequent fracture...